Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-3.10%)
As of: Sep 30, 2026 · 2:04 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Non-Current Assets (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) reported Non-Current Assets of $49.23 million for Q2 2026, down 18.8% from $60.6 million a year earlier and down 6.0% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Non-Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics posted Non-Current Assets of $55.57 million, down 16.6% from FY2024.

  • By year, Non-Current Assets came in at $66.64 million in FY2024 (-23.0%) and $86.57 million in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q4 2023.
  • Year over year, Non-Current Assets has now declined in each of the last seven quarters, with an average decline of 20.4% over the last seven quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $52.4 million (Q1 2026), $55.57 million (Q4 2025) and $58.12 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.23 Mn
Mar 31, 2026 52.40 Mn
Dec 31, 2025 55.57 Mn
Sep 30, 2025 58.12 Mn
Jun 30, 2025 60.60 Mn
Mar 31, 2025 64.67 Mn
Dec 31, 2024 66.64 Mn
Sep 30, 2024 76.06 Mn
Jun 30, 2024 78.33 Mn
Mar 31, 2024 79.76 Mn
Dec 31, 2023 86.57 Mn
API Access

Metagenomi Therapeutics, Inc. Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=MGX&period=max&api_key=YOUR_API_KEY